CN101406630A - Medicament for treating coronary heart disease - Google Patents
Medicament for treating coronary heart disease Download PDFInfo
- Publication number
- CN101406630A CN101406630A CNA2008101592665A CN200810159266A CN101406630A CN 101406630 A CN101406630 A CN 101406630A CN A2008101592665 A CNA2008101592665 A CN A2008101592665A CN 200810159266 A CN200810159266 A CN 200810159266A CN 101406630 A CN101406630 A CN 101406630A
- Authority
- CN
- China
- Prior art keywords
- portions
- radix
- heart disease
- coronary heart
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicine for treating coronary heart disease, which comprises the following compositions in weight portion: 15 portions of rhizoma gastrodiae, 18 portions of dogwood fruit, 12 portions of saffron, 18 portions of rhizoma polygonati, 12 portions of hemlock parsley, 20 portions of salvia miltiorrhiza, 12 portions of peach kernel, 10 portions of red paeonia, 10 portions of secretio bufonis, 50 portions of notoginseng, 24 portions of radix astragali, 18 portions of ginseng, 15 portions of aconite, 12 portions of cassia twig, 18 portions of root of straight ladybell, 12 portions of earthworm, 60 portions of fresh hawthorn, 30 portions costus root, 30 portions of endodermis of chicken gizzard, 3 portions of muskiness, and 6 portions of borneol. The invention has the advantages of no side effect, no stimulation, significant healing efficacy, effective rate of 86 percent, and curative rate over 65 percent.
Description
Technical field
The present invention relates to a kind of Chinese drugs agentia for the treatment of coronary heart disease, specifically a kind of medicament for the treatment of coronary heart disease.
Background technology
The medicine of existing treatment coronary heart disease is a lot, though therapeutic effect is all arranged, undesirable, effective percentage is low, general effective percentage less than 48%, cure rate less than 37%, and easily recurrence.
The invention reside in provides a kind of treatment coronary heart disease effective percentage height, cure rate height, the medicament of the treatment coronary heart disease that has no side effect.
Summary of the invention
The invention reside in provides a kind of treatment coronary heart disease effective percentage height, cure rate height, the medicament of the treatment coronary heart disease that has no side effect.
Technical scheme of the present invention is achieved in that the medicament of treatment coronary heart disease, the medicine that it is made up of the deal of following raw material of Chinese medicine prescription proportioning, Rhizoma Gastrodiae 12-20, Fructus Corni 10-18, Stigma Croci 6-12, Rhizoma Polygonati 10-20, Rhizoma Chuanxiong 10-15, Radix Salviae Miltiorrhizae 15-20, Semen Persicae 10-12, Radix Paeoniae Rubra 10-18, Venenum Bufonis 10-18, Radix Notoginseng 10-50, Radix Astragali 12-24, Radix Codonopsis 10-18, Radix Aconiti Lateralis Preparata 10-18, Ramulus Cinnamomi 10-12, Radix Adenophorae (Radix Glehniae) 10-18, Pheretima 10-18, Fructus Crataegi 30-90, Radix Aucklandiae 20-60, Endothelium Corneum Gigeriae Galli 20-50, Moschus 2-6, Borneolum Syntheticum 4-8.
Medicine of the present invention: the medicament of treatment coronary heart disease, the medicine that it is made up of the deal of following raw material of Chinese medicine prescription proportioning, Rhizoma Gastrodiae 15, Fructus Corni 18, Stigma Croci 12, Rhizoma Polygonati 18, Rhizoma Chuanxiong 12, Radix Salviae Miltiorrhizae 20, Semen Persicae 12, Radix Paeoniae Rubra 10, Venenum Bufonis 10, Radix Notoginseng 50, the Radix Astragali 24, Radix Ginseng 18, Radix Aconiti Lateralis Preparata 15, Ramulus Cinnamomi 12, Radix Adenophorae (Radix Glehniae) 18, Pheretima 12, Fructus Crataegi 60, the Radix Aucklandiae 30, Endothelium Corneum Gigeriae Galli 30, Moschus 3, Borneolum Syntheticum 6.The processing of will adding medicine to cooks makes super cell grade micropowder (more than 300 orders) Chinese medicine powder, and it is standby to receive bottle.
Instructions of taking:
1, method: powder 9 grams of at every turn getting it filled, be placed in 300 milliliters of boiled water and soaked 15-20 minute, once obey down twice-daily, taking medicine after meal.
2, the course of treatment: 7-15 days is a course of treatment.
3, criterion of therapeutical effect: with the sx is effectively, is recovery from illness with the transference cure.
Advantage of the present invention is to have no side effect, and is non-stimulated, evident in efficacy, and effective percentage 86%, cure rate be more than 65%, and the lighter 1-2 course of treatment, weight person 3-5 can cure a course of treatment.
The specific embodiment:
Embodiment: get Rhizoma Gastrodiae 15, Fructus Corni 18, Stigma Croci 12, Rhizoma Polygonati 18, Rhizoma Chuanxiong 12, Radix Salviae Miltiorrhizae 20, Semen Persicae 12, Radix Paeoniae Rubra 10, Venenum Bufonis 10, Radix Notoginseng 50, the Radix Astragali 24, Radix Ginseng 18, Radix Aconiti Lateralis Preparata 15, Ramulus Cinnamomi 12, Radix Adenophorae (Radix Glehniae) 18, Pheretima 12, Fructus Crataegi 60, the Radix Aucklandiae 30, Endothelium Corneum Gigeriae Galli 30, Moschus 3, Borneolum Syntheticum 6.The processing of will adding medicine to cooks makes super cell grade micropowder (more than 300 orders) Chinese medicine powder, and it is standby to receive bottle.
Instructions of taking:
1, method: at every turn obey 9 grams, day clothes secondary, taking medicine after meal.
2, the course of treatment: 7-15 days is a course of treatment.
3, criterion of therapeutical effect: with the sx is effectively, is recovery from illness with the transference cure.
4, taboo: hot, peppery, wine, anger.
Advantage of the present invention is to have no side effect, and is non-stimulated, evident in efficacy, and effective percentage 86%, cure rate be more than 65%, and the lighter 1-2 course of treatment, weight person 3-5 can cure a course of treatment.
Claims (2)
1, the medicament of treatment coronary heart disease, it is characterized in that: the medicine that it is made up of the deal of following raw material of Chinese medicine prescription proportioning, Rhizoma Gastrodiae 12-20, Fructus Corni 10-18, Stigma Croci 6-12, Rhizoma Polygonati 10-20, Rhizoma Chuanxiong 10-15, Radix Salviae Miltiorrhizae 15-20, Semen Persicae 10-12, Radix Paeoniae Rubra 10-18, Venenum Bufonis 10-18, Radix Notoginseng 10-50, Radix Astragali 12-24, Radix Codonopsis 10-18, Radix Aconiti Lateralis Preparata 10-18, Ramulus Cinnamomi 10-12, Radix Adenophorae (Radix Glehniae) 10-18, Pheretima 10-18, Fructus Crataegi 30-90, Radix Aucklandiae 20-60, Endothelium Corneum Gigeriae Galli 20-50, Moschus 2-6, Borneolum Syntheticum 4-8.
2, the medicament of treatment coronary heart disease according to claim 1, it is characterized in that: the medicine that it is made up of the deal of following raw material of Chinese medicine prescription proportioning, Rhizoma Gastrodiae 15, Fructus Corni 18, Stigma Croci 12, Rhizoma Polygonati 18, Rhizoma Chuanxiong 12, Radix Salviae Miltiorrhizae 20, Semen Persicae 12, Radix Paeoniae Rubra 10, Venenum Bufonis 10, Radix Notoginseng 50, the Radix Astragali 24, Radix Ginseng 18, Radix Aconiti Lateralis Preparata 15, Ramulus Cinnamomi 12, Radix Adenophorae (Radix Glehniae) 18, Pheretima 12, Fructus Crataegi 60, the Radix Aucklandiae 30, Endothelium Corneum Gigeriae Galli 30, Moschus 3, Borneolum Syntheticum 6.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101592665A CN101406630B (en) | 2008-11-27 | 2008-11-27 | Medicament for treating coronary heart disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101592665A CN101406630B (en) | 2008-11-27 | 2008-11-27 | Medicament for treating coronary heart disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101406630A true CN101406630A (en) | 2009-04-15 |
| CN101406630B CN101406630B (en) | 2011-08-24 |
Family
ID=40569975
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008101592665A Expired - Fee Related CN101406630B (en) | 2008-11-27 | 2008-11-27 | Medicament for treating coronary heart disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101406630B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101716236B (en) * | 2009-12-18 | 2012-06-27 | 潘根起 | Chinese medicinal composition for adjunctively treating left ventricular insufficiency after acute myocardial infarction and preparation method thereof |
| CN102764326A (en) * | 2012-07-23 | 2012-11-07 | 高航 | Traditional Chinese medicine composition for treating coronary disease |
| CN103784888A (en) * | 2014-02-23 | 2014-05-14 | 曹小松 | Traditional Chinese medicine for treating coronary atherosclerotic heart disease caused by qi deficiency and blood stasis |
-
2008
- 2008-11-27 CN CN2008101592665A patent/CN101406630B/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101716236B (en) * | 2009-12-18 | 2012-06-27 | 潘根起 | Chinese medicinal composition for adjunctively treating left ventricular insufficiency after acute myocardial infarction and preparation method thereof |
| CN102764326A (en) * | 2012-07-23 | 2012-11-07 | 高航 | Traditional Chinese medicine composition for treating coronary disease |
| CN102764326B (en) * | 2012-07-23 | 2014-07-09 | 高航 | Traditional Chinese medicine composition for treating coronary disease |
| CN103784888A (en) * | 2014-02-23 | 2014-05-14 | 曹小松 | Traditional Chinese medicine for treating coronary atherosclerotic heart disease caused by qi deficiency and blood stasis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101406630B (en) | 2011-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100356972C (en) | Chinese medicine for treating amblyopia and myopia | |
| CN100441212C (en) | Chinese medicine for treating cardiac failure | |
| CN101057946A (en) | Traditional Chinese medicine for treating heart disease | |
| CN104436148A (en) | Traditional Chinese medicine composition for treating hypotension caused by qi-blood deficiency | |
| CN103301426A (en) | Capsule for invigorating circulation and benefiting heart | |
| CN106266936A (en) | A kind of medicine for the treatment of of cancer pain | |
| CN103341049A (en) | Dendrobium huoshanense-containing traditional Chinese medicine composition with anti-fatigue effect, and preparation method thereof | |
| CN104721425A (en) | Traditional Chinese medicine foot bath powder for improving sleep, and preparation and use methods thereof | |
| CN103142865A (en) | Traditional Chinese medicine for treating hypertension | |
| CN104173986A (en) | Traditional Chinese medicine for treating heart failure | |
| CN101406630B (en) | Medicament for treating coronary heart disease | |
| CN102846693B (en) | Composition used for relieving exercise-induced fatigue, and preparation method and application thereof | |
| CN103007064A (en) | Traditional Chinese medicine (TCM) composition for treating cerebral posterior circulation ischemia | |
| CN104208609B (en) | It is peaceful to pacify brain | |
| CN101406596B (en) | Medicament for treating dry eye | |
| CN101406631B (en) | Medicament for treating hyperkinetic symptom of children | |
| CN101703736B (en) | Chinese medicament for treating coronary disease | |
| CN103182025B (en) | Traditional Chinese medicine composition for treating bradyarrhythmia, and application thereof | |
| CN101732622A (en) | Chinese medicament for treating ischidrosis | |
| CN104189392A (en) | Traditional Chinese medicinal composition for treating skin itch and preparation method thereof | |
| CN105125894B (en) | A kind of Chinese medicine composition for treating headache | |
| CN103341120A (en) | Purely Chinese herbal preparation for reducing blood pressure | |
| CN104800599A (en) | Traditional Chinese medicinal composition for treating deficiency of kidney-yin | |
| CN104352996A (en) | Traditional Chinese medicine composition for treating cerebral infarction | |
| CN102988898A (en) | Traditional Chinese medicine composition used for treating aspermatism and oligospermatism of man |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110824 Termination date: 20111127 |